Page 142 - Withrow and MacEwen's Small Animal Clinical Oncology, 6th Edition
P. 142

CHAPTER 6  Diagnostic Imaging in Oncology  121


                                                                 mast cell tumor in a small group of dogs. 112  Further specific uses
                                                                 of FDG and use of targeted agents will increase the usefulness
                                                                 of PET/CT in the future. The utility of PET/MRI in veterinary
  VetBooks.ir                                                    medicine is undergoing investigation. 

                                                                 Lymph Node Assessment

                                                                 Assessing LNs for evidence of metastasis is an important part of
                                                                 staging cancer patients. B-mode ultrasound, CT, and MRI pro-
                                                                 vide information on the size, shape, and echogenicity of LNs,
                                                                 providing a good initial assessment provided the LN is accessible.
                                                                 For example, only the medial iliac and cranial aspect of the inter-
                                                                 nal iliac LNs are typically visible with abdominal ultrasound; as a
                                                                 result, ultrasonography is a less sensitive imaging modality than
                                                                 cross-sectional imaging techniques, such as CT and MRI, for the
                                                                 detection of nodal metastasis from perineal tumors where the
                                                                 sacral node is likely to be the draining node (e.g., apocrine gland
                                                                 anal sac adenocarcinomas). 52,113
                                                                   Using absolute LN size to determine malignancy can be prob-
                                                                 lematic because of the substantial variation in dog breed sizes and
                                                                 the fact that metastatic LNs are not always enlarged. Many studies
                                                                 have looked at normalizing LN size to account for this variation,
           • Fig. 6.14  A dorsal plane reconstruction of the head obtained 3 minutes   but with variable success. 114,115  CT assessment of sternal LNs sug-
           after injection of a contrast medium around a rostral right mandibular mass   gest that a ratio of sternal LN height to the height of the sec-
           demonstrates multiple lymphatic vessels draining into the right mandibular   ond sternebra of >1 and a precontrast attenuation of 37.5 HU
           lymph node (arrow) identifying this as the sentinel lymph node. It is impor-  or greater is highly predictive of malignancy. 115  The presence of
           tant to note that further cytologic or histopathologic assessment of the   micrometastasis is also common and may not result in an absolute
           sentinel lymph node is required to determine whether there is evidence of   change in LN size.  A change in the shape of an LN from oval
                                                                               4
           metastasis within this lymph node.                    to round, as indicated by a short axis-to-long axis ratio of >0.7,
                                                                 and loss of definition of the LN hilus are seen more frequently
                                                                 with malignant than reactive LNs. 116,117  The signal characteris-
           bone-specific radiopharmaceutical that enables generation of   tics of LNs should also be considered as, in combination with
           highly detailed skeletal images that are superior for detection of   other parameters, this may be helpful in differentiating benign
           bone metastasis compared with planar or single-photon emission   from malignant LNs. On ultrasound, both reactive and malignant
           computerized tomography (SPECT) imaging with Tc99m-methyl   LNs tend to be hypoechoic and may have a heterogeneous echo-
           diphosphonate (Tc99m-MDP).  To date, the only reported use   genicity, but there is no consistent pattern to differentiate these
                                   95
           of NaF F-18 is in equine orthopedic disease and in four normal   processes.   116,118  MRI perinodal contrast enhancement is seen
           immature dogs. 96,97  Labeling F-18 with the thymidine analog FLT   more commonly in cats and dogs with reactive lymphadenitis. 119
                    18
           (3′-deoxy-3′[ F]fluorothymidine) allows the imaging of proliferat-  Metastatic disease to the LNs often alters the vascularity and
           ing tissues, including neoplastic tissues. FLT reflects DNA synthesis   these  changes  may  be  evident  with  Doppler  ultrasonography.
           and was successful in detecting initial disease, response to therapy,   The blood supply to normal LNs is predominantly centered at
           and predicting relapse in a small group of dogs with lymphoma.    the hilus, whereas malignant LNs trend to having a peripheral
                                                            98
           PET/CT functional imaging of tumor hypoxia using dogs with   or mixed peripheral and hilar distribution with a greater number
           spontaneously arising nasal tumors injected with copper(II)-diace-  of vessels. 26,117,118  Displacement of the central hilar vessels, more
           tyl-bis(N -methylthiosemicarbazone) (Cu-ATSM)  has also been   than one central vessel, pericapsular vessels, and peripheral vessels
                 4
           performed and evaluated for radiation boost planning. 99  that do not connect with the central vessel have all been associated
                                                                              29
             The baseline metabolic rate of normal tissues must be known   with malignancy.  Vascular resistance may increase in malignant
           to accurately interpret PET images. The standardized uptake value   LNs as a result of vascular compression from tumor cells, and
           (SUV) is a semiquantitative measure of FDG uptake that is directly   this can be detected by measuring resistive index and pulsatility
           proportional to the metabolic activity. 100  Increased SUV measure-  index. 120   Increases in  these  parameters  are suggestive of  malig-
           ment correlates to subjective increased hypermetabolic activity vis-  nancy when seen in combination with other sonographic find-
           ible on PET images. No specific cut-offs have been established for   ings. 26,116  Fundamentally, however, there is no one sonographic
           malignancy in veterinary medicine, whereas in human medicine   measurement that is predictive of malignancy; using a combina-
           an SUV max  >2.5 is predictive of malignancy in patients with soli-  tion of size, shape, and vascularity of the LN, in addition to fine-
           tary pulmonary nodules. 101  However, multiple studies have found   needle aspirate cytology of the LN, is recommended to increase
           that visual interpretation by an experienced reader is equivalent to   the predictive value for detection of metastatic disease. 120
           or superior compared with SUV measurements. 102–104     Detection of the sentinel or draining LN is very important
             Multiple tumor types in dogs and cats have been shown to be   in the clinical staging and determining the treatment options
           hypermetabolic on PET or PET/CT, including but not limited   and prognosis for animals and people with cancer (see  Chap-
           to lymphoma, mast cell tumor, osteosarcoma, oral squamous cell   ter 9). Assessment of LNs is based on size, shape, and contrast
           carcinoma, mammary carcinoma, fibrosarcoma, and primary lung   enhancement, but there is wide variation in accuracy using these
           tumors. 98,105–111  F-18 FDG was shown to correlate with grade of   parameters due in part to the subjectivity of evaluation. 4,118
   137   138   139   140   141   142   143   144   145   146   147